http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200023016-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4f4e27efe063c6cfdc546cebc6ac6b78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5351c62aee4203f2be2944f21a6def2 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2030-8813 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6812 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57434 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-7233 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2018-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83f42fbacf832a46dc8006fbefcb88d0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b797052e50b443656cec509e8962dade http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8ca99e8648b026e859f9bab11827aed http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74521177f2da885272d616423365429e |
| publicationDate | 2020-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20200023016-A |
| titleOfInvention | A biomaker composition for diagnosing prostate cancer comprising a kynurenine pathway metabolome |
| abstract | The present invention provides a biomarker composition for diagnosing prostate pressure, which comprises a kynurenine, anthranilate, or a kynurenine pathway metabolite, which is kynurenine and anthranilate, as an active ingredient; Prostate cancer diagnostic composition comprising an agent capable of measuring the biomarker level; Prostate cancer diagnostic kit comprising the composition for diagnosing prostate cancer; (a) measuring a biomarker level comprising a kynurenine pathway metabolite, which is kynurenine, anthranilate, or kynurenine and anthranilate in a biological sample of the subject, and (b) measured bio The present invention relates to a method for providing information for diagnosing prostate cancer, comprising comparing a marker level with a control group, and using the biomarker composition for diagnosing prostate cancer according to the present invention, it is difficult to secure the accuracy of a conventional diagnosis. For prostate cancer diagnosis using can be significantly or alternatively to significantly improve the accuracy of the diagnosis, it can be widely used in various industries such as medical field. |
| priorityDate | 2018-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 71.